Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection
in patients with multiple myeloma and may improve their response to chemotherapy.
PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work
compared to no antibiotics in preventing early infection in patients with multiple myeloma.
Phase:
Phase 3
Details
Lead Sponsor:
Gary Morrow
Collaborators:
Eastern Cooperative Oncology Group National Cancer Institute (NCI)